Lexeo Therapeutics, Inc. - LXEO

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
May 20, 2026 Chief Operating Officer S D 1,302.0 5.074 6,606.35 130,088.0 View
May 20, 2026 Chief Executive Officer S D 3,342.0 5.0649 16,926.9 336,764.0 View
Apr 30, 2026 A A 50,000.0 0.0 0.0 50,000.0 View
Apr 07, 2026 Chief Executive Officer S D 55,000.0 5.6934 313,137.0 340,106.0 View
Mar 17, 2026 Chief Executive Officer A A 2,623.0 2.644 6,935.21 395,106.0 View
Mar 17, 2026 Chief Operating Officer A A 5,930.0 2.644 15,678.92 131,390.0 View
Feb 20, 2026 Chief Operating Officer S D 721.0 9.27 6,683.67 63,476.0 View
Feb 20, 2026 Chief Operating Officer S D 3,016.0 6.3972 19,293.96 125,460.0 View
Feb 20, 2026 Chief Executive Officer S D 10,173.0 6.382 64,924.09 392,483.0 View
Feb 17, 2026 Chief Medical Officer A A 297,000.0 0.0 0.0 297,000.0 View
Feb 17, 2026 Chief Medical Officer A A 49,500.0 0.0 0.0 49,500.0 View
Feb 06, 2026 Chief Operating Officer A A 260,000.0 0.0 0.0 260,000.0 View
Feb 06, 2026 Chief Operating Officer A A 65,000.0 0.0 0.0 128,476.0 View
Feb 06, 2026 Chief Executive Officer A A 646,665.0 0.0 0.0 646,665.0 View
Feb 06, 2026 Chief Executive Officer A A 161,665.0 0.0 0.0 402,656.0 View
Feb 06, 2026 Chief Financial Officer A A 226,665.0 0.0 0.0 226,665.0 View
Feb 06, 2026 Chief Financial Officer A A 44,665.0 0.0 0.0 89,665.0 View